866-997-4948(US-Canada Toll Free)

United States Biosimilars Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 98 Pages

Notes:
Sales, means the sales volume of Biosimilars
Revenue, means the sales value of Biosimilars

This report studies sales (consumption) of Biosimilars in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Sandoz International
Hospira
Teva Pharmaceutical
Dr. Reddys Laboratories
Biocon
Mylan
Amgen
Celltrion
Roche Diagnostics
Merck KGaA

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Biosimilars in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Biosimilars Market Report 2017
1 Biosimilars Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars
1.2.1 Type I
1.2.2 Type II
1.3 Application of Biosimilars
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Biosimilars (2012-2022)
1.4.1 United States Biosimilars Sales and Growth Rate (2012-2022)
1.4.2 United States Biosimilars Revenue and Growth Rate (2012-2022)

2 United States Biosimilars Competition by Manufacturers
2.1 United States Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biosimilars Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biosimilars Average Price by Manufactures (2015 and 2016)
2.4 Biosimilars Market Competitive Situation and Trends
2.4.1 Biosimilars Market Concentration Rate
2.4.2 Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Biosimilars Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Biosimilars Sales and Market Share by States (2012-2017)
3.2 United States Biosimilars Revenue and Market Share by States (2012-2017)
3.3 United States Biosimilars Price by States (2012-2017)

4 United States Biosimilars Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Biosimilars Sales and Market Share by Type (2012-2017)
4.2 United States Biosimilars Revenue and Market Share by Type (2012-2017)
4.3 United States Biosimilars Price by Type (2012-2017)
4.4 United States Biosimilars Sales Growth Rate by Type (2012-2017)

5 United States Biosimilars Sales (Volume) by Application (2012-2017)
5.1 United States Biosimilars Sales and Market Share by Application (2012-2017)
5.2 United States Biosimilars Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Biosimilars Manufacturers Profiles/Analysis
6.1 Sandoz International
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Biosimilars Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sandoz International Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Hospira
6.2.2 Biosimilars Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Hospira Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Teva Pharmaceutical
6.3.2 Biosimilars Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teva Pharmaceutical Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Dr. Reddys Laboratories
6.4.2 Biosimilars Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Dr. Reddys Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Biocon
6.5.2 Biosimilars Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biocon Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Mylan
6.6.2 Biosimilars Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Mylan Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Amgen
6.7.2 Biosimilars Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Celltrion
6.8.2 Biosimilars Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Roche Diagnostics
6.9.2 Biosimilars Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Roche Diagnostics Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Merck KGaA
6.10.2 Biosimilars Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Merck KGaA Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Biosimilars Manufacturing Cost Analysis
7.1 Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilars

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Biosimilars Market Forecast (2017-2022)
11.1 United States Biosimilars Sales, Revenue Forecast (2017-2022)
11.2 United States Biosimilars Sales Forecast by Type (2017-2022)
11.3 United States Biosimilars Sales Forecast by Application (2017-2022)
11.4 Biosimilars Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Biosimilars
Table Classification of Biosimilars
Figure United States Sales Market Share of Biosimilars by Type in 2015
Table Application of Biosimilars
Figure United States Sales Market Share of Biosimilars by Application in 2015
Figure United States Biosimilars Sales and Growth Rate (2012-2022)
Figure United States Biosimilars Revenue and Growth Rate (2012-2022)
Table United States Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table United States Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilars Sales Share by Manufacturers
Figure 2016 Biosimilars Sales Share by Manufacturers
Table United States Biosimilars Revenue by Manufacturers (2015 and 2016)
Table United States Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biosimilars Revenue Share by Manufacturers
Table 2016 United States Biosimilars Revenue Share by Manufacturers
Table United States Market Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biosimilars Average Price of Key Manufacturers in 2015
Figure Biosimilars Market Share of Top 3 Manufacturers
Figure Biosimilars Market Share of Top 5 Manufacturers
Table United States Biosimilars Sales by States (2012-2017)
Table United States Biosimilars Sales Share by States (2012-2017)
Figure United States Biosimilars Sales Market Share by States in 2015
Table United States Biosimilars Revenue and Market Share by States (2012-2017)
Table United States Biosimilars Revenue Share by States (2012-2017)
Figure Revenue Market Share of Biosimilars by States (2012-2017)
Table United States Biosimilars Price by States (2012-2017)
Table United States Biosimilars Sales by Type (2012-2017)
Table United States Biosimilars Sales Share by Type (2012-2017)
Figure United States Biosimilars Sales Market Share by Type in 2015
Table United States Biosimilars Revenue and Market Share by Type (2012-2017)
Table United States Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilars by Type (2012-2017)
Table United States Biosimilars Price by Type (2012-2017)
Figure United States Biosimilars Sales Growth Rate by Type (2012-2017)
Table United States Biosimilars Sales by Application (2012-2017)
Table United States Biosimilars Sales Market Share by Application (2012-2017)
Figure United States Biosimilars Sales Market Share by Application in 2015
Table United States Biosimilars Sales Growth Rate by Application (2012-2017)
Figure United States Biosimilars Sales Growth Rate by Application (2012-2017)
Table Sandoz International Basic Information List
Table Sandoz International Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sandoz International Biosimilars Sales Market Share (2012-2017)
Table Hospira Basic Information List
Table Hospira Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hospira Biosimilars Sales Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical Biosimilars Sales Market Share (2012-2017)
Table Dr. Reddys Laboratories Basic Information List
Table Dr. Reddys Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Dr. Reddys Laboratories Biosimilars Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Biosimilars Sales Market Share (2012-2017)
Table Mylan Basic Information List
Table Mylan Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Biosimilars Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Biosimilars Sales Market Share (2012-2017)
Table Celltrion Basic Information List
Table Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celltrion Biosimilars Sales Market Share (2012-2017)
Table Roche Diagnostics Basic Information List
Table Roche Diagnostics Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Diagnostics Biosimilars Sales Market Share (2012-2017)
Table Merck KGaA Basic Information List
Table Merck KGaA Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck KGaA Biosimilars Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biosimilars
Table Distributors/Traders List
Figure United States Biosimilars Production and Growth Rate Forecast (2017-2022)
Figure United States Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Table United States Biosimilars Production Forecast by Type (2017-2022)
Table United States Biosimilars Consumption Forecast by Application (2017-2022)
Table United States Biosimilars Sales Forecast by States (2017-2022)
Table United States Biosimilars Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *